Shalby Limited Approves Key Appointments and Completes Acquisition of Stake in Singapore Subsidiary
Shalby Limited, during its board meeting on August 12, 2026, approved crucial corporate governance matters, including the appointment of a new director and the acquisition of the remaining stake in its subsidiary, Shalby Global Technologies Pte. Ltd. The company also released unaudited financial results for the quarter ended June 30, 2026.The Board meeting saw the approval of Unaudited Standalone and Consolidated Financial results for the quarter ending June 30, 2026, along with a Limited Review Report issued by the Statutory Auditors. Furthermore, the board approved the Cost Audit Report on the company’s cost records for the financial year ended March 31, 2026.
In terms of governance appointments, Mr. Shanay Vikram Shah (DIN: 02726541) was appointed as an Additional Director designated as Whole-Time Director for a term of five consecutive years, effective August 12, 2026. The appointment, subject to shareholder approval at the upcoming Annual General Meeting, places him as a Key Managerial Personnel of the company. M/s. PricewaterhouseCoopers Services LLP was also appointed as Internal Auditors for the financial year 2026–27, following a recommendation by the Audit Committee.
The Board approved the Notice for convening the 22nd Annual General Meeting, scheduled to be held on Thursday, September 10, 2026 at 4:00 p.m. IST.
Subsidiary Acquisition Details
A significant corporate action undertaken during the meeting was the acquisition of the remaining shares in Shalby Global Technologies Pte. Ltd. (SGTPL), a step-down subsidiary of Shalby Limited. Shalby Medtech Limited (the wholly-owned subsidiary, formerly known as Mars Medical Devices Limited) acquired 10,000 equity shares from Dr. Vikram Shah and Mr. Shanay Shah.This acquisition completed on August 12, 2026. Post-acquisition, SGTPL became a wholly-owned subsidiary of Shalby Medtech Limited. The transaction was conducted at an arms' length basis for a consideration of SGD 2 per share, aggregating to SGD 20,000.
The operational details of the acquired entity include:
| Particulars | Details |
|---|---|
| Target Entity Name | Shalby Global Technologies Pte. Ltd. (SGTPL) |
| Type of Acquisition | Acquisition of remaining equity shares |
| Shares Acquired | 10,000 equity shares |
| Percentage Acquired | 0.67% |
| Consideration | SGD 2 per share, totaling SGD 20,000 |
Financial Performance Overview
The company provided detailed financial reporting for the quarter ended June 30, 2026, covering both standalone and consolidated results.Consolidated Financial Results (Quarter Ended June 30, 2026)
Total Income for the period reached 3,386.38 Million. The company reported a profit of 104.96 Million from continuing operations.
| Metric | Qtr Ended Jun 30, 2026 (Million) | Qtr Ended Mar 31, 2026 (Million) | Qtr Ended Jun 30, 2025 (Million) | Year Ended Mar 31, 2026 (Million) |
|---|---|---|---|---|
| Revenue from Operations | 3,312.24 | 2,874.45 | 2,964.26 | 11,414.29 |
| Total Income | 3,386.38 | 2,955.24 | 3,034.34 | 11,682.20 |
| Total Expenses | 3,189.43 | 2,859.18 | 2,807.81 | 11,076.59 |
| Profit before Tax | 196.95 | 96.06 | 226.53 | 605.61 |
Standalone Financial Results (Quarter Ended June 30, 2026)
The company reported a Total Income of 2,590.66 Million for the quarter. Profit before tax stood at 338.85 Million.
| Metric | Qtr Ended Jun 30, 2026 (Million) | Qtr Ended Mar 31, 2026 (Million) | Qtr Ended Jun 30, 2025 (Million) | Year Ended Mar 31, 2026 (Million) |
|---|---|---|---|---|
| Revenue from Operations | 2,537.91 | 2,248.54 | 2,365.64 | 8,985.58 |
| Total Income | 2,590.66 | 2,304.46 | 2,421.77 | 9,234.15 |
Segment Performance Analysis
As per Indian Accounting Standard 108 'Operating Segments,' the Group reports two primary segments: Healthcare Services and Manufacturing & Trading of Implants.| Segment/Metric | Qtr Ended Jun 30, 2026 (Million) | Qtr Ended Mar 31, 2026 (Million) | Qtr Ended Jun 30, 2025 (Million) | Year Ended Mar 31, 2026 (Million) |
|---|---|---|---|---|
| Healthcare Services | ||||
| Segment Revenue | 2,888.14 | 2,472.32 | 2,683.63 | 10,101.36 |
| Profit/ (Loss) Before Tax | 311.76 | 170.76 | 325.67 | 952.82 |
| Segment Assets | 12,704.34 | 12,649.66 | 12,872.15 | 12,649.66 |
| Manufacturing & Trading of Implants | ||||
| Segment Revenue | 424.10 | 402.13 | 280.62 | 1,312.92 |
| Profit/ (Loss) Before Tax | (114.81) | (74.71) | (99.15) | (347.21) |
SHALBY Stock Price Movement
Shares of Shalby Limited slipped by 2.89% on Wednesday, closing at ₹157.28 after falling ₹4.67 from the previous close. The stock traded with a volume of 97,370 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: